Lead compounds for the development of SARS-CoV-2 3CL protease inhibitors

Journal:
Nature Communications
Published:
DOI:
10.1038/s41467-021-22362-2
Affiliations:
7
Authors:
12
Institutions Authors Share
Columbia University Irving Medical Center (CUIMC), CU, United States of America (USA)
4.000000
0.33
Columbia University in the City of New York (CU), United States of America (USA)
3.000000
0.25
Aaron Diamond AIDS Research Center (ADARC), CU, United States of America (USA)
3.000000
0.25
WuXi AppTec, China
2.000000
0.17